Your browser version may not work well with NCBI's Web applications. More information here...
1: EMBO J. 1995 Aug 1;14(15):3741-51.Click here to read Links

Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG.

Molecular Endocrinology Laboratory, Imperial Cancer Research Fund, London, UK.

A conserved region in the hormone-dependent activation domain AF2 of nuclear receptors plays an important role in transcriptional activation. We have characterized a novel nuclear protein, RIP140, that specifically interacts in vitro with this domain of the estrogen receptor. This interaction was increased by estrogen, but not by anti-estrogens and the in vitro binding capacity of mutant receptors correlates with their ability to stimulate transcription. RIP140 also interacts with estrogen receptor in intact cells and modulates its transcriptional activity in the presence of estrogen, but not the anti-estrogen 4-hydroxytamoxifen. In view of its widespread expression in mammalian cells, RIP140 may interact with other members of the superfamily of nuclear receptors and thereby act as a potential co-activator of hormone-regulated gene transcription.

PMID: 7641693 [PubMed - indexed for MEDLINE]

PMCID: PMC394449

Patient Drug Information

  • Estrogen (Cenestin® , Enjuvia® , Estrace® , ...)

    Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estrogen...

  • Tamoxifen (Nolvadex® )

    Your doctor has prescribed tamoxifen for you. Tamoxifen comes as a tablet to take by mouth.

  • Source: AHFS Consumer Medication Information